Benefits and harms of extending the duration of dual antiplatelet therapy after percutaneous coronary intervention with drug-eluting stents: A meta-analysis

Kwok, Chun Shing, Bulluck, Heerajnarain, Ryding, Alisdair D. and Loke, Yoon K. (2014) Benefits and harms of extending the duration of dual antiplatelet therapy after percutaneous coronary intervention with drug-eluting stents: A meta-analysis. The Scientific World Journal, 2014. ISSN 1537-744X

Full text not available from this repository. (Request a copy)

Abstract

The optimal duration of dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI) is unclear.

Item Type:	Article
Faculty \ School:	Faculty of Medicine and Health Sciences > Norwich Medical School
UEA Research Groups:	Faculty of Science > Research Groups > Norwich Epidemiology Centre Faculty of Medicine and Health Sciences > Research Groups > Norwich Epidemiology Centre Faculty of Medicine and Health Sciences > Research Groups > Health Services and Primary Care Faculty of Medicine and Health Sciences > Research Centres > Population Health Faculty of Medicine and Health Sciences > Research Centres > Lifespan Health
Depositing User:	Pure Connector
Date Deposited:	07 Jul 2014 13:14
Last Modified:	28 Mar 2025 05:59
URI:	https://ueaeprints.uea.ac.uk/id/eprint/48916
DOI:	10.1155/2014/794078

Actions (login required)

View Item